Can Combination Rescue Inhalers help Adolescents Control Asthma Flare Ups?
Trial Objectives
In adults with asthma, adding an inhaled corticosteroid called budesonide into albuterol rescue inhalers helps relieve asthma symptoms and prevent flare-ups. Researchers are investigating if this treatment also helps adolescents with asthma reduce their symptoms.Volunteers in the ACADIA study will be randomly assigned to receive either an inhaler with a combination of budesonide and albuterol or an inhaler with just albuterol (containing no corticosteroid). During clinic visits, they will receive breathing tests and record symptoms. At home, volunteers will have to complete a twice-daily electronic health log to record their symptoms and inhaler use.
Who Can Participate
Participants must be at least 12 and less than 18 years old and have been diagnosed with asthma at least 12 months ago. They must be currently be using an inhaled asthma medication and have had 1-3 severe asthma episodes requiring additional medication or medical treatment over the last 12 months.
Age: 12-18 Gender: Any
Estimated Time Commitment
Approximately 58 weeks (13 months).
Payment & Reimbursement
Payment: Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Cynthia Wainscoat
303.398.1259
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
AstraZeneca